Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DuPont de Nemours Inc (DD) vs Medpace Holdings Inc (MEDP) Price & Performance

DuPont de Nemours IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

DuPont de Nemours Inc vs Medpace Holdings Inc — how do they compare? DuPont de Nemours Inc trades at $144.26 (market cap $19.51B), while Medpace Holdings Inc trades at $609.54 (market cap $16.90B). The key difference: DuPont de Nemours Inc is the larger of the two by market cap, and DuPont de Nemours Inc pays a 1.66% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

DDMEDP
Market Cap
$19.51B$16.90B
Sector
Basic MaterialsTechnology
52-Week High
$154.59$620.59
52-Week Low
$90.24$393.42
Enterprise Value
$20.90B$16.52B
Dividend Yield
1.66%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

Read more on DD

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP